Symptoms such as forgetfulness, loss of concentration and disorientation can be early signs of dementia or Alzheimer’s disease (AD).
MENUCO CORPORATION and BIRKMAYER LABORATORIES, patent holders for the nutritional supplement ENADA® and ENADAlert®, have been awarded a new U.S.
The Coenzyme nicotinamide adenine dinucleotide (NADH) has been used as medication in 17 patients suffering from dementia of the Alzheimer type in an open label trial.
Click this link to view the entire study: CURRICULUM BIRKMAYER JOERG G.D.
ENADA ® , a natural energy-enhancing nutritional supplement, tested by researchers at Georgetown University Medical Center, has achieved significant improvement in relieving the symptoms of people suffering from Chronic Fatigue Syndrome (CFS).
Chlorophyll has been called Nature’s Green Magic.
NADH (Enada), also known as Coenzyme 1, has shown great promise in helping to alleviate the symptoms of Parkinson’s disease, Alzheimer’s disease, depression, Chronic Fatigue Syndrome, and other diseases.
The aim of the study was to test the hypothesis if supplemented NADH is able to enhance the available cellular energy prior and during physical exercise as well as enhance after exertion on highly conditioned athletes.
A nutritional supplement based on an energy-giving natural enzyme can help in some cases of chronic fatigue syndrome, researchers said yesterday.
After hearing about the amazing, far-reaching benefits of the coenzyme nicotinamide adenine dinucleotide (NADH), I was extremely interested in interviewing the developer.